OVERVIEW

Tepezza

Tepezza (teprotumumab-trbw) is an insulin-like growth factor-1 receptor inhibitor used to treat Thyroid Eye disease.

Teprotumumab-trbw, an insulin-like growth factor-1 receptor inhibitor (IGF-1R), is a fully human IgG1 monoclonal antibody produced in Chinese hamster ovary (CHO-DG44) cells. It has a molecular weight of approximately 148 kilodaltons.

Tepezza Info

The recommended dose of TEPEZZA is an intravenous infusion of 10 mg/kg for the initial dose followed by an intravenous infusion of 20 mg/kg every three weeks for 7 additional infusions.

Tepezza Side Effects

The most common side effects include: 

  • muscle spasm,
  • nausea,
  • hair loss,
  • diarrhea,
  • fatigue,
  • high blood sugar (hyperglycemia),
  • hearing impairment,
  • dry skin,
  • changes in taste, and
  • headache

FINANCIAL ASSISTANCE

Patient Assistance Programs

There are several programs patients can sign up for that will assist in treatment costs:

Resources

To learn more about this treatment, browse the resources below.

Order Form

To download the order form for this treatment, click below.

Tepezza

Ready to get started?

Contact us to chat with one of our helpful scheduling specialists!